Unknown

Dataset Information

Cytokine responses in nonlesional psoriatic skin as clinical predictor to anti-TNF agents.


ABSTRACT:

Background

A major issue with the current management of psoriasis is our inability to predict treatment response.

Objective

Our aim was to evaluate the ability to use baseline molecular expression profiling to assess treatment outcome for patients with psoriasis.

Methods

We conducted a longitudinal study of 46 patients with chronic plaque psoriasis treated with anti-TNF agent etanercept, and molecular profiles were assessed in more than 200 RNA-seq samples.

Results

We demonstrated correlation between clinical response and molecular changes during the course of the treatment, particularly for genes responding to IL-17A/TNF in keratinocytes. Intriguingly, baseline gene expressions in nonlesional, but not lesional, skin were the best marker of treatment response a

SUBMITTER: Tsoi LC 

PROVIDER: S-EPMC9451046 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature